JYHB2200416 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2022-08-03 | | | | | view |
JYHB1900941 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2019-08-08 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | Certificate Issued | 2020-06-01 | view |
JYHB2400215 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2024-05-14 | | | | | view |
JYHB2001028 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-25 | | | Filed | 2020-06-29 | view |
JYHZ2200249 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | License Renew | 2022-09-10 | | | | | view |
JYHB1801183 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2018-09-28 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | Certificate Issued | 2018-11-26 | view |
JYHB2300744 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2023-12-24 | | | | | view |
JYHB1900962 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2019-08-12 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | In Review | 2019-08-10 | view |
JYHB2200418 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2022-08-03 | | | | | view |
JYHB2400214 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2024-05-14 | | | | | view |
JYHB2001027 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-25 | | | Filed | 2020-06-29 | view |
JYHB2101092 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2021-05-11 | | | | | view |
CYHS2302787 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs(4) | Generic Drug | 2023-10-17 | | QILU Pharmaceutical Co Ltd | | | view |
JYHB1900961 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2019-08-12 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | In Review | 2019-08-10 | view |
JYHB2001019 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2020-06-29 | | | Filed | 2020-07-01 | view |
JYHZ2200248 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | License Renew | 2022-09-10 | | | | | view |
JYHB1900940 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2019-08-08 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | Certificate Issued | 2020-06-01 | view |
JYHB2101091 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2021-05-11 | | | | | view |
CYHS2302789 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs(4) | Generic Drug | 2023-10-17 | | QILU Pharmaceutical Co Ltd | | | view |
JYHB1900959 | 枸橼酸伊沙佐米胶囊 | Ixazomib citrate | Capsule | Chemical Drugs | Supplementary Application | 2019-08-12 | 武田药品(中国)有限公司 | Takeda Pharmaceutical (China) Company LIMITED | In Review | 2019-08-10 | view |